Published in Blood Weekly, March 10th, 2005
"The assays were evaluated using p24 antigen panel of 31 HIV-1 subtypes (n=124), 25 HIV-1 seroconversion panels (n=176) HIV-1 antibody positive samples including group M subtypes and group 0 (n=559), HIV-2 positive samples (n=110), and unselected HIV negative samples from four French private laboratories (n=1005)," researchers in France report.
"The results showed that, overall, HIV combined Ag/Ab assays...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.